ResMed (RMD)

Cost of Revenue

$602.43M

Quarterly · Period ending: · USD

RMD logo

RMD Cost of Revenue

Latest reported$602.43M
RMD Quarterly Cost of Revenue ($0.00 → $602.43M)
High-resolution chart · PNG

RMD cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

ResMed Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
602,428,000
540,427,000
538,148,000
514,762,000
527,923,000
525,328,000
530,814,000
507,290,000
518,930,000
515,403,000
493,400,000
502,261,000
504,671,000
499,146,000
454,029,000
409,484,000
392,231,000
373,303,000
390,556,000
397,726,000
385,407,000
321,509,000
337,528,000
313,283,000
320,971,000
319,793,000
309,027,000
276,001,000
287,114,000
270,318,000
267,369,000
245,186,000
261,159,000
247,339,000
251,481,000
218,054,000
232,910,000
214,490,000
221,326,000
196,266,000
217,158,000
193,999,000
188,031,000
173,028,000
193,634,000
171,066,000
159,730,000
143,086,000
153,953,000
145,970,000
135,582,000
129,680,000
154,759,000
144,132,000
143,825,000
131,083,000
145,460,000
138,577,000
134,023,000
129,720,000
143,021,000
130,756,000
119,987,000
108,058,000
117,055,000
112,076,000
110,929,000
96,814,000
95,251,000
88,922,000
91,955,000
90,804,000
101,067,000
85,269,000
81,348,000
73,963,000
74,103,000
128,758,000
66,670,000
62,309,000
66,988,000
61,414,000
54,690,000
47,008,000
45,649,000
38,159,000
35,515,000
31,322,000
33,287,000
33,727,000
29,868,000
25,720,000
30,331,000
25,809,000
23,454,000
20,889,000
19,439,000
19,005,000
17,087,000
15,296,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.